Metwon XR 25 Tablet is a once-daily, extended-release formulation of metoprolol succinate, a beta1-selective adrenoceptor antagonist. It is indicated for the treatment of hypertension, stable angina pectoris, and symptomatic heart failure. The tablet is designed to provide a controlled release of metoprolol succinate over a 24-hour period, allowing for consistent blood pressure control and reduced peak-to-trough variability. In patients with hypertension, Metwon XR 25 Tablet has been shown to significantly reduce systolic and diastolic blood pressure, with minimal effect on pulse rate. It has also been demonstrated to be effective in reducing the risk of cardiovascular events, including myocardial infarction, stroke, and cardiovascular death, in patients with symptomatic heart failure. Additionally, Metwon XR 25 Tablet has been found to be safe and well-tolerated in patients with stable angina pectoris, with a low incidence of adverse effects. As a once-daily treatment, Metwon XR 25 Tablet offers a convenient and consistent regimen for patients requiring long-term beta blocker therapy.

Dosage & How to Use